Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

DON in Pediatric Cerebral Malaria — Stella

Home/Malaria, Cerebral/DON in Pediatric Cerebral Malaria

View on ClinicalTrials.gov

Recruiting

Back to Malaria, Cerebral trials

DON in Pediatric Cerebral Malaria

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

Malawi

Ndirande Research Clinic, Blantyre

Queen Elizabeth Central Hospital, Blantyre

Key details

Phase

Early testing / Safety & dosing

Sponsor

Douglas Postels, MD, MS

Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)

Enrollment target

~152 participants

Started

August 2022

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

12 Months and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.